Amarin and ViewRay Stock See Action From Activist Investors
Yahoo! Finance
Sarissa Capital is pushing to get a slate of directors on the board of pharmaceutical firm Amarin. Hudson Executive disclosed a large stake in radiation-treatment equipment maker ViewRay.
Continue Reading